Can AI Help Cure America’s Healthcare Pricing Problem?
AI is not a silver bullet, but its thoughtful application to administrative automation offers one of the most realistic paths to reducing healthcare costs without sacrificing quality.
AI is not a silver bullet, but its thoughtful application to administrative automation offers one of the most realistic paths to reducing healthcare costs without sacrificing quality.
As AI-enabled coding increasingly adjudicates and reimburses claims on the first pass, often at higher levels, payers face a growing challenge: traditional cost-containment mechanisms are unable to keep pace.
Technology alone won’t solve prior authorization. But refusing to adopt it guarantees the status quo: a system where insurers operate at machine speed, providers operate at human speed, and patients pay the price in delayed care.
Health informatics leaders at NYU Langone Health think fully autonomous clinical AI is coming in the next five years or so, with algorithms soon able to manage routine tasks like blood pressure medication titration and diabetic retinopathy screening without human oversight. They argue automation is not just about efficiency, but also a practical and necessary solution to workforce shortages and system inefficiencies.
Temperature-sensitive medications represent one of the most critical operational and regulatory challenges in modern pharmacy management.
The promise of automation in RCM is undeniable, but achieving it requires more than simply adopting new tools. Hospitals must take deliberate steps to prepare their people, processes, and systems for change.
By keeping our AI and ML grounded in real-world medicine, we can shape a future where prior authorization works smarter, faster, and better for everyone involved.
Ochsner Health is expanding its use of Latent Health’s AI platform after its reduced medication prior authorization times to just 4-5 minutes. The technology is designed to both streamline pharmacists’ workflows as well as improve patients’ access to medications.
Healthcare technology has shifted from a back-office function to a strategic imperative. This evolution presents a powerful opportunity to redefine organizations’ futures.
Cohere Health raked in $90 million in Series C capital, taking its total funding to date to $200 million. This round of funding cements Cohere as the emerging winner in the prior authorization tech category, according to Michael Greeley, general partner at Flare Capital Partners.
How to turn analytics into actual policy outcomes.
In a webinar sponsored by Jotform, scheduled for Thursday, March 13 at 2 pm ET, panelists will discuss how health tech companies approach data automation and how practices implement it.
The operational benefits of automated eligibility and payment workflows are clear, but its impact on people — both patients and staff — may be even more profound.
In a webinar sponsored by Jotform, scheduled for Wednesday March 5 at 1pm ET, panelists will discuss how health tech vendors and healthcare practices approach data automation and how they can collaborate effectively.
Tech-enabled services with humans in the loop are vital components to healthcare organizations’ overall prosperity. Here are three tools that every RCM leader needs in their toolkit when approaching automation.
Patient flow automation startup Qventus closed a $105 million Series D financing round. The company’s technology is used by more than 115 hospitals and health systems, including Northwestern Medicine, Banner Health and Allina Health.